World's Best Scientists 2026 revealed!
Stanley J. Goldsmith

Stanley J. Goldsmith

D-Index & Metrics

Medicine

D-Index
73
Citations
18262
World Ranking
19671
National Ranking
9798

Stanley J. Goldsmith publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stanley J. Goldsmith sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stanley J. Goldsmith D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley J. Goldsmith sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stanley J. Goldsmith is affiliated with Cornell University in the United States, focusing their research primarily in the field of neuroscience. Their work spans several subfields including cellular and molecular neuroscience, cognitive neuroscience, behavioral neuroscience, genetics, and endocrinology, diabetes, and metabolism.

The scientist's research topics encompass memory and neural mechanisms, neurotransmitter receptor influence on behavior, neuroscience and neuropharmacology research, stress responses and cortisol, effects of estrogen and related hormones, menopause health impacts and treatments, as well as olfactory and sensory function studies.

Stanley J. Goldsmith has contributed to a number of recent papers, including:

  • Perirhinal to prefrontal circuit in methamphetamine induced recognition memory deficits, 2023, Neuropharmacology
  • Estrogen receptor beta signaling enhances extinction memory recall for heroin-conditioned cues in a sex- and region-specific manner, 2024, Translational Psychiatry
  • Perirhinal cortex to the nucleus accumbens circuit in novelty salience following methamphetamine self-administration, 2024, Addiction Neuroscience

The venues where Stanley J. Goldsmith frequently publishes include Neuropharmacology, Translational Psychiatry, and Addiction Neuroscience.

Frequent collaborators in their research projects are:

  • Katharine H. Nelson
  • Jordan S. Carter
  • Stacia I. Lewandowski
  • Michael D. Scofield
  • Carmela M. Reichel

Stanley J. Goldsmith's body of work reflects a focus on how neural circuits and receptor signaling influence memory, motivation, and behavior, particularly under conditions related to substance use and hormone impacts. Their studies explore the interactions between specific brain regions such as the perirhinal cortex, prefrontal cortex, and nucleus accumbens, with an emphasis on behavioral and molecular changes induced by drug administration and hormonal signaling.

Best Publications

  • NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

    Matthew H. Kulke;Lowell B. Anthony;David L. Bushnell;Wouter W. de Herder

  • The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum

    J. Philip Boudreaux;David S. Klimstra;Manal M. Hassan;Eugene A. Woltering

  • Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

    Neil H. Bander;Matthew Ivan Milowsky;David M. Nanus;Lale Kostakoglu

  • PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin’s Disease

    Lale Kostakoglu;Morton Coleman;John P. Leonard;Ichiei Kuji

  • Clinical Role of FDG PET in Evaluation of Cancer Patients

    Lale Kostakoglu;Harry Agress;Stanley J. Goldsmith

  • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

    Scott T. Tagawa;Matthew I. Milowsky;Michael Morris;Shankar Vallabhajosula

  • Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

    Charles A. Mack;Shailen R. Patel;Eric A. Schwarz;Pat Zanzonico

  • Possible axonal regrowth in late recovery from the minimally conscious state.

    Henning U. Voss;Aziz M. Uluç;Jonathan P. Dyke;Richard Watts

  • Phase I Trial of Yttrium-90--Labeled Anti--Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

    Matthew I. Milowsky;David M. Nanus;Lale Kostakoglu;Shankar Vallabhajosula

  • Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

    Richard I. Fisher;Mark S. Kaminski;Richard L. Wahl;Susan J. Knox

  • In Vitro Characterization of Radiolabeled Monoclonal Antibodies Specific for the Extracellular Domain of Prostate-specific Membrane Antigen

    Peter M. Smith-Jones;Shankar Vallabahajosula;Stanley J. Goldsmith;Vincent Navarro

  • Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors

    Matthew Ivan Milowsky;David M. Nanus;Lale Kostakoglu;Christine E. Sheehan

  • The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0

    Edward B. Silberstein;Abass Alavi;Helena R. Balon;Susan E.M. Clarke

  • Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.

    Neil H. Bander;Edouard J. Trabulsi;Lale Kostakoglu;Daniel Yao

  • First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer

    John A. Barrett;R. Edward Coleman;Stanley J. Goldsmith;Shankar Vallabhajosula

  • Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.

    Lale Kostakoglu;John P. Leonard;John P. Leonard;Ichiei Kuji;Morton Coleman;Morton Coleman

  • PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.

    Lale Kostakoglu;Ruth Hardoff;Rosna Mirtcheva;Stanley J Goldsmith

  • Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.

    Peter M Smith-Jones;Shankar Vallabhajosula;Vincent Navarro;Diego Bastidas

  • Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen.

    Neil H. Bander;David M. Nanus;Matthew Ivan Milowsky;Lale Kostakoglu

  • Total-Hip Arthroplasty: Periprosthetic Indium-111-Labeled Leukocyte Activity and Complementary Technetium-99m-Sulfur Colloid Imaging in Suspected Infection

    Christopher J. Palestro;Chun K. Kim;Alfred J. Swyer;James D. Capozzi

Frequent Co-Authors

Neil H. Bander
Neil H. Bander Cornell University
David M. Nanus
David M. Nanus Cornell University
Morton Coleman
Morton Coleman Cornell University
Himisha Beltran
Himisha Beltran Harvard University
Paul J. Christos
Paul J. Christos Cornell University
John P. Leonard
John P. Leonard Cornell University
John W. Babich
John W. Babich Cornell University
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Homer A. Macapinlac
Homer A. Macapinlac The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers a diverse range of related online degrees and flexible career pathways ideal for those seeking roles beyond traditional clinical practice. Health science is a rapidly growing field, and pursuing a cheapest online health science degree enables students to gain valuable foundational knowledge at an affordable cost.

For those considering healthcare leadership, earning a master's degree can open doors to management roles. There are numerous cheapest mha programs online healthcare for students aiming to become healthcare administrators or managers, making advanced education more accessible.

If you aspire to reach the highest levels of nursing, a Doctor of Nursing Practice (DNP) degree is a popular choice. Many institutions offer dnp online programs cheap so nurses can balance work and studies while advancing their clinical expertise.

Pharmacy is another field with promising online opportunities. A 3-year online pharmd program can prepare graduates for pharmacy licensure in a more flexible and accelerated format.

These online programs expand access, affordability, and flexibility, helping a broader range of students enter healthcare careers without the constraints of traditional campus learning.

Best Scientists Citing Stanley J. Goldsmith

Trending Scientists

Recently Published Articles